within Pharmacolibrary.Drugs.ATC.D;

model D07AC16
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 0.001,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Hydrocortisone aceponate is a synthetic corticosteroid used primarily for topical application in veterinary medicine, particularly for the management of inflammatory and pruritic skin disorders in dogs. It is not commonly used or approved for human use.</p><h4>Pharmacokinetics</h4><p>No published human or animal pharmacokinetic studies with numerical PK parameters (bioavailability, clearance, volume of distribution, etc.) were found for hydrocortisone aceponate using standard scientific literature sources as of June 2024.</p><h4>References</h4><ol><li><p>Wohlrab, J, et al., &amp; Kreft, B (2010). Hydrocortisone aceponate activity and benefit/risk ratio in relation to reference topical glucocorticoids. <i>Skin pharmacology and physiology</i> 23(4) 177â€“182. DOI:<a href=&quot;https://doi.org/10.1159/000288164&quot;>10.1159/000288164</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20185975/&quot;>https://pubmed.ncbi.nlm.nih.gov/20185975</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D07AC16;
